P.J. Visser

Discipline

Psychologie (10)

Type de document

Articles (18) Recensions (1)

Co-auteur

Date

Source

Mot-clé

Alzheimer's disease (17) Amyloid (14) Biochemical markers (14) biomarqueur (13) Human beings (11) maladie (10) âge (10) Proteins (10) Dementia (10) Cerebrospinal fluid (10) Age (10) Age (10) maladie (10) protéine (9) information (9) Apolipoprotein E (9) Weights and measures (9) Mild cognitive impairment (9) plasma (9) pathologie (8) Pathology (8) Cognition (8) Proteomics (7) cohorte (7) besoin (6) Older people (6) risque (5) Diagnosis (5) Risk (5) Performance (5)

Documents écrit par P.J. Visser (18) | parle de P.J. Visser (0)

Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.
L. Shi et al.
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
F. Küçükali et al.
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
A. Delvenne et al. (14 juin 2022)
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.
B.M. Tijms et al. (2 août 2021)
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.
L. Shi et al. (2021)
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
B.M. Tijms et al. (1 déc. 2020)
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset.
S. Hong et al. (22 nov. 2020)
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
E. Konijnenberg et al. (27 mai 2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
S. Westwood et al. (2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
L. Shi et al. (2020)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
L. Shi et al.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
M. Kim et al.
Inflammatory biomarkers in Alzheimer's disease plasma.
A.R. Morgan et al.
A metabolite-based machine learning approach to diagnose Alzheimer-type dementia in blood: Results from the European Medical Information Framework for Alzheimer disease biomarker discovery cohort.
D. Stamate et al. (2019)
MRI predictors of amyloid pathology: results from the EMIF-AD Multimodal Biomarker Discovery study.
M. Ten Kate et al. (27 sept. 2018)
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics.
I. Bos et al. (6 juil. 2018)
The need for harmonisation and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group.
A. Costa et al. (17 avr. 2017)
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
W.J. Jansen et al. (2015)